Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 967 of 1,261

  1. US 7923535

    Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  2. US 7922999

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  3. US 7919260

    Screening methods using GPR52

    Takeda Pharmaceutical Company Limited · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  4. US 7919594

    Human anti-CD100 antibodies

    VACCINEX, INC. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  5. US 7919621

    Tricyclic inhibitors of 5-lipoxygenase

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  6. US 7919618

    Synthesis of piperazines, piperidines and related compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  7. US 7919588

    Netrin receptors

    The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  8. US 7919636

    Purifications of pomegranate ellagitannins and their uses thereof

    The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  9. US 7919607

    Nucleic acids encoding humanized anti-tag 72 CC49 antbodies

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  10. US 7919104

    Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  11. US 7919108

    Taxane coatings for implantable medical devices

    Cook Regentec LLC · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  12. US 7919246

    SEMA4D in cancer diagnosis, detection and treatment

    Sagres Discovery, Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  13. US 7919301

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  14. US 7919473

    IRNA agents targeting VEGF

    Alnylam Pharmaceuticals, Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  15. US 7919475

    Compositions and methods for improving heart function

    The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  16. US 7919484

    Combination therapy

    Xenon Pharmaceuticals Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  17. US 7919477

    Multiple CpG oligodeoxynucleotides and their use to induce an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  18. US 7919579

    Imaging and therapeutic targeting of prostate and bladder tissues

    The Board of Regents of the University of Texas System · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  19. US 7919520

    Inhibitors of tace

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  20. US 7919496

    Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes

    Xenon Pharmaceuticals Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  21. US 7919523

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  22. US 7919079

    Cancer immunotherapy compositions and methods of use

    The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  23. US 7919513

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  24. US 7918899

    Variably crosslinked tissue

    Biomedical Design, Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.